Odonate Therapeutics (ODTC)
Odonate, Inc. is a common stock listing on OTC Markets for a healthcare-sector issuer that currently has no significant operations. The company was originally founded in 2013 under the name Odonate Therapeutics, Inc. and adopted its current name in March 2023. It is based in New York, New York. The available description indicates a limited operating profile, so the listing is best viewed in the context of the corporate shell rather than an active pharmaceutical business.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ODTC
|
—
|
—
|
—
|
—
|
—
|
—
|
Great
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
53.25 M
|
—
|
—
|
—
|
—
|
—
|
—
|
